SCHEMBL21687789

SCHEMBL21687789

N#Cc1ccc(-c2c(C#N)cccc2[Si](c2ccccc2)(c2ccccc2)c2ccccc2)c(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 1/20 0.31
HTR6 P50406 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
ALDH1A1 P00352 2/20 0.31
TSHR P16473 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 2/20 0.31
TDP2 O95551 2/20 0.31
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 2/20 0.30
RORC P51449 1/20 0.30
HTT P42858 1/20 0.30
PTGER4 P35408 1/20 0.30
STAT3 P40763 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687569 0.97 HRH1 (0.33) HRH1HTR6PTGER4
SCHEMBL21688186 0.91 MAPT (0.32) SMN1; SMN2ALDH1A1TSHRMEN1KMT2A
SCHEMBL21688020 0.91 HRH1 (0.35) HRH1HTR6SMN1; SMN2TDP2PTGER4
SCHEMBL21687562 0.89 HRH1 (0.32) HRH1HTR6MAPTHTTPTGER4
SCHEMBL21687980 0.88 SMN1; SMN2 (0.35) SMN1; SMN2ALDH1A1TSHRMEN1KMT2A
SCHEMBL21687842 0.87 SMN1; SMN2 (0.32) HRH1HTR6SMN1; SMN2ALDH1A1TSHR
SCHEMBL21688009 0.87 HRH1 (0.35) HRH1HTR6SMN1; SMN2ALDH1A1TDP2
SCHEMBL21688249 0.87 SMN1; SMN2 (0.36) HRH1HTR6SMN1; SMN2TDP2HIF1A
SCHEMBL21688071 0.86 HRH1 (0.34) HRH1HTR6SMN1; SMN2ALDH1A1TSHR
SCHEMBL21687828 0.85 PTGER4 (0.33) ALDH1A1TDP2PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 HRH1 1158/4885HTR6 3591/4885SMN1; SMN2 4039/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 HRH1 1158/4885HTR6 3591/4885SMN1; SMN2 4039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.